Date published: 2026-5-15

1-800-457-3801

SCBT Portrait Logo
Seach Input

Fliz1 Inhibitors

Fliz1 inhibitors are a class of chemical compounds that selectively target the FLIZ1 protein, a zinc finger transcription factor involved in regulating gene expression. These inhibitors work by interfering with the protein's ability to bind DNA, altering transcriptional activity. FLIZ1 contains zinc finger domains, which are motifs commonly found in transcription factors and responsible for specific interactions with DNA sequences. The inhibitors often disrupt these interactions by either directly competing for the DNA-binding domain or altering the structural conformation of FLIZ1, thereby preventing it from binding to its target sequences. Inhibiting FLIZ1 can lead to changes in the expression of a broad array of genes under its regulatory control, affecting cellular processes like differentiation, proliferation, and responses to external stimuli.

Chemically, Fliz1 inhibitors tend to be small molecules designed to fit into the DNA-binding pockets of FLIZ1 or its allosteric sites. Some compounds may also target co-factors required for FLIZ1's activity, thereby preventing the transcription factor from recruiting other proteins essential for forming active transcriptional complexes. Inhibition mechanisms vary, from reversible binding at active sites to covalent modification of crucial residues within the FLIZ1 protein. Many Fliz1 inhibitors are designed with high specificity for this transcription factor to minimize off-target effects and unintended interactions with other proteins. Structural biology techniques like X-ray crystallography and NMR are often employed to optimize the interactions between Fliz1 inhibitors and their target, enabling fine-tuning of their chemical properties for maximum efficacy in biological research applications.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Staurosporine

62996-74-1sc-3510
sc-3510A
sc-3510B
100 µg
1 mg
5 mg
$82.00
$153.00
$396.00
113
(4)

A potent kinase inhibitor that can inhibit a wide range of kinases potentially involved in Fliz1 activation or stabilization.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

A phosphatidylinositol 3-kinase (PI3K) inhibitor, can disrupt PI3K-dependent signaling pathways that might regulate Fliz1 activity.

SB 431542

301836-41-9sc-204265
sc-204265A
sc-204265B
1 mg
10 mg
25 mg
$82.00
$216.00
$416.00
48
(1)

An inhibitor of the TGF-β type I receptor ALK5, which can modulate the TGF-β signaling pathway that might intersect with Fliz1 regulation.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

An mTOR inhibitor, can affect Fliz1 by altering the protein synthesis pathways that Fliz1 relies on for its expression.

ZM-447439

331771-20-1sc-200696
sc-200696A
1 mg
10 mg
$153.00
$356.00
15
(1)

An Aurora kinase inhibitor that can disrupt cell cycle progression, potentially affecting Fliz1 levels or activity.

Thapsigargin

67526-95-8sc-24017
sc-24017A
1 mg
5 mg
$136.00
$446.00
114
(2)

A sarco/endoplasmic reticulum Ca2+ ATPase (SERCA) pump inhibitor, can lead to increased cytosolic calcium levels which may impact Fliz1 function.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$135.00
$1085.00
115
(2)

A proteasome inhibitor, can prevent the degradation of proteins that regulate Fliz1 or its pathways.

PD173074

219580-11-7sc-202610
sc-202610A
sc-202610B
1 mg
5 mg
50 mg
$47.00
$143.00
$680.00
16
(1)

A selective FGFR inhibitor which can disrupt the fibroblast growth factor signaling that may interact with Fliz1 regulatory mechanisms.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

An inhibitor of c-Jun N-terminal kinase (JNK), can alter signaling pathways that potentially control Fliz1 activity.

Imatinib

152459-95-5sc-267106
sc-267106A
sc-267106B
10 mg
100 mg
1 g
$26.00
$119.00
$213.00
27
(1)

A tyrosine kinase inhibitor known to target BCR-ABL, c-KIT, and PDGFR, can affect signaling pathways regulating Fliz1.